Outcomes and Prognostic Factors of Second Allogeneic ...

This study aimed to investigate the outcomes and prognostic factors of patients who underwent allo-HCT2 after ALL relapse.

Second Allogeneic Hematopoietic Cell Transplantation for Relapsed ...

Second allogeneic hematopoietic cell transplantation ... allograft (HCT1), but prognostic factors for outcomes are poorly characterized.

Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative treatment option frequently used in patients with acute lymphoblastic ...

Paper: Outcomes and Prognostic Factors of Second Allogeneic ...

Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative treatment option frequently used in patients with acute lymphoblastic ...

Long-term outcome and prognostic factors of second allogeneic ...

Several factors have been reported to impact on the outcome after second transplant, such as younger age, absence of GvHD, chronic GvHD after ...

Prognostic factors of second hematopoietic allogeneic stem cell ...

In conclusion, relapse after HSCT carries a high risk of poor outcomes for patients with hematological malignancies. However, there is some hope for selected ...

Second Allogeneic Hematopoietic Cell Transplantation for Relapsed ...

Second allogeneic hematopoietic cell transplantation (HCT2) is potentially curative for adults with acute myeloid leukemia (AML) or myelodysplastic neoplasm ( ...

Second Allogeneic Hematopoietic Cell Transplantation for Relapsed ...

Prognostic factors for outcome after HCT2 for disease relapse after HCT1 ; 1 (Reference) 1.74 (0.58-5.20) 3.19 (1.40-7.29), 0.32 0.006, 1 ( ...

Second Allogeneic Hematopoietic Cell Transplantation for Relapse ...

Second Allogeneic Hematopoietic Cell Transplantation for Relapse in Adults with Acute Myeloid Leukemia: Outcomes and Prognostic Factors ; Naveed Ali · Clinical ...

Long-term outcome and prognostic factors of - ProQuest

Second allogeneic hematopoietic stem cell transplantation (HSCT2) is a frequently used treatment option for relapse of acute leukemia after first allogeneic ...

Outcome and prognostic factors among patients who underwent a ...

The overall survival (OS) at two years, non-relapse mortality (NRM), and relapse mortality (RM) were 30.3%, 40.9%, and 28.8%, respectively. Multivariate ...

A Study from the Adult Acute Lymphoblastic Leukemia Working ...

Request PDF | Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic ...

Outcomes and prognostic factors of adults with acute lymphoblastic ...

To describe outcomes, treatment and prognostic factors that influence survival ... Long-term outcome and prognostic factors of second allogeneic hematopoietic ...

Second Allogeneic Hematopoietic Cell Transplantation for Relapsed ...

A recent report from Seattle describing outcomes of second alloHCT for acute myeloid leukemia (AML) found similar results, with three-year overall survival ...

Prognostic Factors Affecting Outcome after Allogeneic ... - ClinicalKey

Several prognostic factors for the outcome after allogeneic hematopoietic stem-cell transplant (HSCT) from matched unrelated donors have been postulated ...

Long-term outcome and prognostic factors of second allogeneic ...

Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 ...

Prognostic Factors After Second Allogeneic HSCT in Patients With ...

Results from the study were published in the British Journal of Haematology. The Japanese Data Center for Haematopoietic Cell Transplantation ...

[Clinical Outcomes and Prognostic Factors of Allogeneic ...

Allo-HSCT is an effective and safe choice for refractory/relapsed AML patients. DNMT3A R882 mutations and grade II-IV aGVHD are negative prognostic factors.

Reduced intensity conditioning allogeneic stem cell transplantation ...

For patients with no risk factors the 3-year non-relapse mortality rate was 12.5% compared to 46.2% for patients with 2 or more risk factors.

Outcome and Prognostic Factors of Haploidentical Allogeneic ...

Multivariate analysis revealed that pre-HSCT measurable residual disease (MRD) positivity (hazard ratio, 13.275; 95% CI: 2.406–73.243; p = 0.003) ...